{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T15:14:43Z","timestamp":1778944483571,"version":"3.51.4"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001322","name":"South African Medical Research Council","doi-asserted-by":"publisher","award":["43500"],"award-info":[{"award-number":["43500"]}],"id":[{"id":"10.13039\/501100001322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004417","name":"Global Fund to Fight AIDS, Tuberculosis and Malaria","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004417","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.cct.2024.107779","type":"journal-article","created":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T01:53:00Z","timestamp":1733968380000},"page":"107779","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Advancing vaccine research in Africa: A comprehensive analysis of vaccine clinical trials landscape"],"prefix":"10.1016","volume":"149","author":[{"given":"Lindi","family":"Mathebula","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thobile","family":"Malinga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chinwe","family":"Iwu-Jaja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duduzile","family":"Ndwandwe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"34","key":"10.1016\/j.cct.2024.107779_bb0005","doi-asserted-by":"crossref","first-page":"12283","DOI":"10.1073\/pnas.1400472111","article-title":"History of vaccination","volume":"111","author":"Plotkin","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.cct.2024.107779_bb0010","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1080\/21645515.2019.1693720","article-title":"Description of vaccine clinical trials in Africa: a narrative review","volume":"16","author":"Ndwandwe","year":"2020","journal-title":"Hum. Vaccin. Immunother."},{"issue":"8","key":"10.1016\/j.cct.2024.107779_bb0015","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2022-009430","article-title":"Epidemiological impact and cost-effectiveness analysis of COVID-19 vaccination in Kenya","volume":"7","author":"Orangi","year":"2022","journal-title":"BMJ Glob Health."},{"issue":"3","key":"10.1016\/j.cct.2024.107779_bb0020","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1473-3099(11)70008-1","article-title":"Seasonal influenza epidemiology in sub-Saharan Africa: a systematic review","volume":"11","author":"Gessner","year":"2011","journal-title":"Lancet Infect. Dis."},{"issue":"1","key":"10.1016\/j.cct.2024.107779_bb0025","doi-asserted-by":"crossref","first-page":"1939620","DOI":"10.1080\/21645515.2021.1939620","article-title":"Burden of vaccine-preventable diseases, trends in vaccine coverage and current challenges in the implementation of the expanded program on immunization: a situation analysis of Cameroon","volume":"18","author":"Ngwa","year":"2022","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.cct.2024.107779_bb0030","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1200\/GO.21.00096","article-title":"Cancer clinical trials in Africa-an untapped opportunity: recommendations from AORTIC 2019 conference special interest Group in Clinical Trials","volume":"7","author":"Ibraheem","year":"2021","journal-title":"JCO Glob Oncol."},{"key":"10.1016\/j.cct.2024.107779_bb0035","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1200\/JGO.19.00194","article-title":"Partnerships and collaborations: the right alliances for clinical trials in Africa","volume":"6","author":"Solarin","year":"2020","journal-title":"JCO Glob Oncol."},{"issue":"5","key":"10.1016\/j.cct.2024.107779_bb0040","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/eahr.500055","article-title":"Equitably sharing the benefits and burdens of research: Covid-19 raises the stakes","volume":"42","author":"Coleman","year":"2020","journal-title":"Ethics Hum Res."},{"issue":"2","key":"10.1016\/j.cct.2024.107779_bb0045","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.cct.2006.10.001","article-title":"A perspective on African American participation in clinical trials","volume":"28","author":"Shaya","year":"2007","journal-title":"Contemp. Clin. Trials"},{"issue":"2","key":"10.1016\/j.cct.2024.107779_bb0050","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2021-007839","article-title":"COVID-19 vaccines for children and adolescents in Africa: aligning our priorities to situational realities","volume":"7","author":"Govender","year":"2022","journal-title":"BMJ glob Health."},{"issue":"7","key":"10.1016\/j.cct.2024.107779_bb0055","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0277-9536(01)00327-6","article-title":"Reflections and recommendations on research ethics in developing countries","volume":"54","author":"Benatar","year":"2002","journal-title":"Soc. Sci. Med."},{"issue":"8","key":"10.1016\/j.cct.2024.107779_bb0060","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/j.vaccine.2023.01.043","article-title":"Cost of introducing and delivering RTS,S\/AS01 malaria vaccine within the malaria vaccine implementation program","volume":"41","author":"Baral","year":"2023","journal-title":"Vaccine"},{"issue":"10068","key":"10.1016\/j.cct.2024.107779_bb0065","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(16)32621-6","article-title":"Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola ca Suffit!)","volume":"389","author":"Henao-Restrepo","year":"2017","journal-title":"Lancet"},{"issue":"26","key":"10.1016\/j.cct.2024.107779_bb0070","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1056\/NEJMe1606007","article-title":"Implementation of RTS,S\/AS01 Malaria Vaccine--The Need for Further Evidence","volume":"374","author":"Clemens","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.cct.2024.107779_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0209744","article-title":"Current challenges and proposed solutions to the effective implementation of the RTS, S\/AS01 malaria vaccine program in sub-Saharan Africa: a systematic review","volume":"13","author":"Dimala","year":"2018","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.cct.2024.107779_bb0080","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s12936-022-04168-9","article-title":"Challenges and lessons learned during the planning and early implementation of the RTS,S\/AS01(E) malaria vaccine in three regions of Ghana: a qualitative study","volume":"21","author":"Grant","year":"2022","journal-title":"Malar. J."},{"issue":"10016","key":"10.1016\/j.cct.2024.107779_bb0085","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0140-6736(15)00807-7","article-title":"Implementation of the malaria candidate vaccine RTS,S\/AS01","volume":"387","author":"Greenwood","year":"2016","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.cct.2024.107779_bb0090","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/bmb\/ldaa036","article-title":"Vaccination ethics","volume":"137","author":"Giubilini","year":"2021","journal-title":"Br. Med. Bull."},{"key":"10.1016\/j.cct.2024.107779_bb0095","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1472-6939-13-17","article-title":"Ethical and legal constraints to children\u2019s participation in research in Zimbabwe: experiences from the multicenter pediatric HIV ARROW trial","volume":"13","author":"Bwakura-Dangarembizi","year":"2012","journal-title":"BMC Med. Ethics"},{"key":"10.1016\/j.cct.2024.107779_bb0100","author":"(ICTRP) ICTRP"},{"key":"10.1016\/j.cct.2024.107779_bb0105","author":"EDCTP"},{"key":"10.1016\/j.cct.2024.107779_bb0110","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1200\/JGO.19.00189","article-title":"Landscape of oncology clinical trials in Africa","volume":"6","author":"Odedina","year":"2020","journal-title":"JCO Glob Oncol."},{"key":"10.1016\/j.cct.2024.107779_bb0115","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1200\/JGO.19.00315","article-title":"Oncology clinical trials in Africa: partnering for quality","volume":"7","author":"Shamley","year":"2021","journal-title":"JCO Glob Oncol."},{"issue":"1","key":"10.1016\/j.cct.2024.107779_bb0120","article-title":"Correspondence: strengthening capacity, collaboration and quality of clinical research in Africa: EDCTP networks of excellence","volume":"11","author":"Kitau","year":"2009","journal-title":"African Journals OnLine."},{"key":"10.1016\/j.cct.2024.107779_bb0125","doi-asserted-by":"crossref","DOI":"10.1017\/S0950268822001212","article-title":"COVID-19 vaccination rollout in the World Health Organization African region: status at end June 2022 and way forward","volume":"150","author":"Impouma","year":"2022","journal-title":"Epidemiol. Infect."},{"issue":"12","key":"10.1016\/j.cct.2024.107779_bb0130","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2021-007518","article-title":"Tracking the uptake and trajectory of COVID-19 vaccination coverage in 15 west African countries: an interim analysis","volume":"6","author":"Afolabi","year":"2021","journal-title":"BMJ Glob Health."},{"issue":"1","key":"10.1016\/j.cct.2024.107779_bb0135","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/s43856-023-00330-9","article-title":"Assessing COVID-19 vaccine hesitancy and barriers to uptake in sub-Saharan Africa","volume":"3","author":"Wollburg","year":"2023","journal-title":"Commun Med (Lond)."},{"issue":"10","key":"10.1016\/j.cct.2024.107779_bb0140","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1080\/21645515.2018.1522921","article-title":"Special focus on challenges and opportunities for the development and use of vaccines in Africa","volume":"14","author":"Madhi","year":"2018","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.cct.2024.107779_bb0145","doi-asserted-by":"crossref","first-page":"1104828","DOI":"10.3389\/fimmu.2023.1104828","article-title":"The COVID-19, tuberculosis and HIV\/AIDS: Menage a trois","volume":"14","author":"Udoakang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cct.2024.107779_bb0150","first-page":"446328","article-title":"Research challenges in Africa \u2013 an exploratory study on the experiences and opinions of African researchers","author":"Ngongalah","year":"2018","journal-title":"bioRxiv"},{"issue":"7","key":"10.1016\/j.cct.2024.107779_bb0155","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.immuni.2021.06.017","article-title":"COVID-19 vaccine access in Africa: global distribution, vaccine platforms, and challenges ahead","volume":"54","author":"Massinga Loembe","year":"2021","journal-title":"Immunity"},{"issue":"8","key":"10.1016\/j.cct.2024.107779_bb0160","doi-asserted-by":"crossref","first-page":"e288","DOI":"10.1016\/S1473-3099(22)00878-7","article-title":"Opportunities and challenges of leveraging COVID-19 vaccine innovation and technologies for developing sustainable vaccine manufacturing capabilities in Africa","volume":"23","author":"Kana","year":"2023","journal-title":"Lancet Infect. Dis."}],"container-title":["Contemporary Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714424003628?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714424003628?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T08:23:50Z","timestamp":1774254230000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551714424003628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":32,"alternative-id":["S1551714424003628"],"URL":"https:\/\/doi.org\/10.1016\/j.cct.2024.107779","relation":{},"ISSN":["1551-7144"],"issn-type":[{"value":"1551-7144","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advancing vaccine research in Africa: A comprehensive analysis of vaccine clinical trials landscape","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cct.2024.107779","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107779"}}